Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Tricuspid Valve Disease clinical trials
6 of 7 indexed Tricuspid Valve Disease trials are currently recruiting.
Corpus placement: #2,497 of 28,707 conditions by registered trial count.
7 US clinical trials · 6 currently recruiting · #2,497 of 28,707 conditions by registered trial count
Tricuspid Valve Disease: 7 US clinical trials tracked, 6 recruiting.
Tricuspid Valve Disease is the subject of 7 registered US clinical trials on ClinicalTrials.gov, 6 of them currently open to new participants. The most active sponsor is Corvivo Cardiovascular, running 2 of these trials.
Enrollment posture brief
Registry condition tricuspid-valve-disease
OPEN 6 | RECR 86% | LATE 0 | EARLY 0 | RANK #2497 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Adenovirus (86% recruiting · 7 trials)
Tricuspid Valve Disease lists 6 open slots (86% of 7 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Tricuspid Valve Disease on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Tricuspid Valve Disease is recruiting above its size-band peers.
6 of 7 indexed trials (85.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Tricuspid Valve Disease research.
Corvivo Cardiovascular accounts for 2 of 7 trials (28.6%). 5 distinct sponsors appear on at least one study for this condition label.
-
Most Tricuspid Valve Disease trials plan to enrol fewer than 100 people.
Median target enrolment is 78 among the 7 trials that report a genuine target (sentinel values excluded). 5 of those (71.4%) plan for fewer than 100 participants.
-
Tricuspid Valve Disease research is mostly interventional.
7 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
7 total, page 1 of 1
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
Edwards Lifesciences
NCT04097145
CorMatrix Cor TRICUSPID ECM Valve Replacement - Pivotal Study
Corvivo Cardiovascular
NCT05742906
CorMatrix Cor TRICUSPID ECM Valve Replacement Study
Corvivo Cardiovascular
NCT02397668
TRIcvalve biCAVal Valve System for Severe Tricuspid Regurgitation (TRICAV-I)
P+F Products + Features USA
NCT06137807
Clinical Safety and Efficacy of the VDyne Transcatheter Tricuspid Valve Replacement System for the Treatment of Tricuspid Regurgitation ( VISTA-US)
VDyne
NCT05848284
EFS of the DUO System for Tricuspid Regurgitation
CroiValve Limited
NCT05913908
TRISCEND II Pivotal Trial
Edwards Lifesciences
NCT04482062
Phase Distribution
Phase data not available
Top Sponsors
Named interventions
Most-linked intervention names on Tricuspid Valve Disease records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Tricuspid Valve Disease trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Tricuspid Valve Disease page
7 registered trials, 6 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 6 Tricuspid Valve Disease trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Corvivo Cardiovascular sponsors the most Tricuspid Valve Disease trials on record, review their full trial history before evaluating a specific study. See Corvivo Cardiovascular's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Tricuspid Valve Disease condition card totals 7 registered trials; most-linked intervention Optimal Medical Therapy; top US site state Indiana. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.